Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Rule 8.3- Premier Research

19 Mar 2008 18:16

Kyte Funds SPC-Pavillion Active Val19 March 2008 The 'Rule 8.3) - Premier Research' announcement released on today at 15:50 under RNS No 4985Q has been amended. Amendments are identified with an asterisk (*). The full amended text is shown below. FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) KYTE FUNDS SPC - PAVILLION ACTIVE VALUE EQUITY FUND SEGREGATED PORTFOLIO Company dealt in PREMIER RESEARCH GROUP PLC Class of relevant security to which the dealings being disclosed relate (Note 2) ORDINARY SHARES 1P Date of dealing 18TH MARCH 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 41000 (0.0006818%) (2) Derivatives (other than options) 783456 (1.30283%) (3) Options and agreements to purchase/sell Total *842456* (1.371009%) (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 280,000 83.9891P (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) CFD LONG 280,000 83.9891P (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. NONE .............................................................................. Is a Supplemental Form 8 attached? (Note 9) YES/NO Date of disclosure 19TH MARCH 2008 Contact name THOMAS WALKER Telephone number 0207 390 4276 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Dec 20071:08 pmRNSRule 8.3-Premier Research Grp
17th Dec 20078:10 amRNSEPT Disclosure
14th Dec 20072:52 pmRNSRule 8.3- Premier Research Gr
14th Dec 200710:38 amRNSRule 8.3-Premier Research Grp
14th Dec 200710:16 amRNSEPT Disclosure
13th Dec 20079:01 amRNSEPT Disclosure
12th Dec 200712:40 pmRNSRule 8.3-Premier Research Grp
12th Dec 20079:29 amRNSEPT Disclosure
11th Dec 20079:35 amRNSEPT Disclosure
10th Dec 20072:27 pmRNSRule 8.3- Premier Research
10th Dec 20071:23 pmRNSRule 8.3- Premier Research
10th Dec 200711:18 amRNSRule 8.3- Premier Research
10th Dec 20078:41 amRNSEPT Disclosure
7th Dec 200711:18 amRNSRule 8.3- Premier Research
7th Dec 20079:18 amRNSEPT Disclosure
6th Dec 20071:21 pmRNSRule 8.3- Premier Research Gp
6th Dec 200712:13 pmRNSRule 8.3- Premier Research
6th Dec 20079:19 amRNSEPT Disclosure
5th Dec 20078:54 amRNSEPT Disclosure
4th Dec 20079:43 amRNSEPT Disclosure
3rd Dec 20079:17 amRNSEPT Disclosure
30th Nov 200710:00 amRNSEPT Disclosure
30th Nov 20077:01 amRNSOffer Update
29th Nov 20071:29 pmRNSRule 8.3- Premier Research
29th Nov 20079:35 amRNSEPT Disclosure
28th Nov 20079:47 amRNSEPT Disclosure
27th Nov 20078:50 amRNSEPT Disclosure
26th Nov 20079:45 amRNSEPT Disclosure
23rd Nov 200710:04 amRNSEPT Disclosure
22nd Nov 20079:19 amRNSEPT Disclosure
21st Nov 20073:03 pmBUSRule 8.3 - Premier Research Group Plc
21st Nov 20079:38 amRNSEPT Disclosure
20th Nov 20079:03 amRNSEPT Disclosure
16th Nov 200710:06 amRNSEPT Disclosure
14th Nov 20079:11 amRNSEPT Disclosure
13th Nov 20079:31 amRNSEPT Disclosure
12th Nov 20078:09 amRNSEPT Disclosure
9th Nov 20079:40 amRNSEPT Disclosure
8th Nov 20079:03 amRNSEPT Disclosure
7th Nov 20072:55 pmRNSRule 8.3- Premier Research
7th Nov 200712:55 pmRNSRule 8.3- Premier Research
7th Nov 20079:09 amRNSEPT Disclosure
6th Nov 20079:58 amRNSEPT Disclosure
5th Nov 20079:31 amRNSEPT Disclosure
2nd Nov 20074:35 pmRNSRule 8.3- Premier Research
2nd Nov 20078:42 amRNSEPT Disclosure
1st Nov 200710:30 amRNSEPT Disclosure
31st Oct 200710:18 amRNSEPT Disclosure
31st Oct 20078:33 amRNSRule 8.3- Premier Research
31st Oct 20078:32 amRNSRule 8.3 - Premier Research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.